TTUHSC School of Pharmacy
HomeSOPFaculty & Staff Directory

Faculty & Staff Details

Profile for Brian Irons, PharmD, FCCP, BCACP, BC-ADM

Brian Irons

Brian Irons, PharmD, FCCP, BCACP, BC-ADM

  • Professor
  • Other
Office Phone: 806-743-4200 ext 225
Mail Address: 3601 4th St Stop 8162
Lubbock TX 79430-8162


Dr. Irons has been with the TTUHSC School of Pharmacy since 1999 and is a Professor with the Department of Pharmacy Practice specializing in Ambulatory Care on the Lubbock Campus. Dr. Irons is Head of the Ambulatory Care Division within the Department of Pharmacy Practice mentoring fellow division members on all four of our campuses in their teaching, practice, scholarship, and service responsibilities. He is a past Director of the SOPs PGY2 Ambulatory Care Residency in Lubbock and a preceptor for the PGY1 and 2 residents on that campus. He has various teaching responsibilities in didactic lectures, case-based learning, and our experiential program. He is a past Team Leader for the Endocrinology Pharmacotherapy, Case Studies, and Ambulatory Care Elective courses and for the Ambulatory Care Clinical Skills Clerkship. He received his BS and PharmD from the University of Wisconsin – Madison. He completed a Pharmacy Practice Residency at United Hospital in St. Paul, MN and an Ambulatory / Managed Care Residency with the Texas Tech School of Pharmacy. Dr. Irons is certified by the Board of Pharmacy Specialties in both ambulatory care and pharmacotherapy and is also board certified in advanced diabetes management. In 2011 Dr. Irons was named Fellow by the American College of Clinical Pharmacy for sustained excellence in the discipline of clinical pharmacy.

Research Interests

Ambulatory Care
Heart Failure

Selected Publications:

  • Irons BK. Endocrine and Metabolic Disorders. American College of Clinical Pharmacy. 2014;(2014):I-201.
  • Nigro S, Garwood C, Berlie H, Irons BK, Longyhore D, McFarland M, Saseen J, Trewet C. Clinical Pharmacists as Key Members of the Pateint-Centered Medical Home: An Opinion Statement of the Ambulatory Care Practice and Research Network f the American College of Clinical Pharmacy. Pharmacotherapy. 2014;34(1):96-108.
  • Irons BK, Minze MG. Drug Treatment of Type 2 Diabetes Mellitus in Patients for whom metformin is contraindicated. Diabetes, Metabolic Syndrome, and Obesity: Targets and Therapy. 2014;7:15-24.
  • Irons BK. Endocrinology/Rheumatology. American College of Clinical Pharmacy. 2014.
  • Irons BK, Trujillo A, Seifert CF, Simoni JS, Meyerrose GE. Effects of direct renin inhibition on atherosclerotic biomarkers in patients with stable coronary artery disease and type 2 diabetes mellitus. Journal of Cardiovascular Pharmacology and Therapeutics. 2013;18(5):427-432.